Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia

Metabolism: Clinical and Experimental

Volumn 48, Issue 10, 1999, Pages 1294-1302

  Palmieri, Michael ^b   Mazur, Alice ^b   Berry, Gerard T ^b   Ning, Cong ^b   Wehrli, Suzanne ^b   Yager, Claire ^b   Reynolds, Robert ^b   Singh, Rani ^b   Muralidharan, Kasinathan ^b   Langley, Sharon ^b   Elsas II, Louis ^b   Segal, Stanton ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GALACTITOL; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GALACTOSE PHOSPHATE; LACTOSE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DIET RESTRICTION; ENZYME DEFICIENCY; ERYTHROCYTE LEVEL; GALACTOSEMIA; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MUTATION; NEWBORN; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 13044257706     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90271-8     Document Type: Article

References (42)

1. Segal S, Berry GT: Disorders of galactose metabolism, in Scriver CH, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Diseases (ed 7). New York, NY, McGraw-Hill, 1995, pp 967-1000
2. Quan Ma R, Wells HJ, Wells WW: Galactitol in the tissues of a galactosemic child. Am J Dis Child 112:477-478, 1966
3. Quan Ma R, Wells WW: The distribution of galactitol in tissues of rats fed galactose. Biochem Biophys Res Commun 20:486-490, 1965
4. Gitzelmann R, Curtis HC, Schneller I: Galactitol and galactose-1-phosphate in the lens of a galactosemic infant. Exp Eye Res 6:1-3, 1967
5. Van Heyaingen R: Formation of polyols by the lens of the rat with sugar cataracts. Nature 184:194-205, 1959
6. Kinoshita JH: Mechanisms initiating cataract formation. Invest Ophthalmol 13:713-724, 1974
7. Berry GT: The role of polyols in the pathophysiology of hypergalactosemia. Eur J Pediatr 154:S53-S64, 1995 (suppl)
8. Roe TF, Ng WG, Bergren WR, et al: Urinary galactitol in galactosemic patients. Biochem Med 7:266-273, 1973
9. Yamazaki T, Makato M, Hayashi M: Urinary and severe galactitol in galactosemic patients. Acta Paediatr Jpn 33:61-70, 1991
10. Jakobs C, Schweitzer S, Dorland B: Galactitol in galactosemia. Eur J Pediatr 154:S50-S52, 1995 (suppl)
11. Elsas LJ, Langley SD, Paulk ME, et al: A molecular approach to galactosemia. Eur J Pediatr 154:S21-S27, 1995 (suppl)
12. Elsas LJ, Langley SD, Steele E, et al: A strategy to identify new biochemical phenotypes and molecular genotypes. Am J Hum Genet 56:636-639, 1995
13. Wehrli SL, Berry GT, Palmieri JM, et al: Urinary galactonate in patients with galactosemia: Quantitation by nuclear magnetic spectroscopy. Pediatr Res 42:855-861, 1997
14. Ning C, Kuhara T, Matsumoto I: Simultaneous metabolic profile studies of three patients with fatal infantile mitochondrial myopathy-de Toni-Fanconi-Debre syndrome by GC/MS. Clin Chim Acta 247:197-200, 1996
15. Dhalquist A: A fluorometric method for the assay of galactose-1-phosphate in red blood cells. J Lab Clin Invest 78:931-938, 1971
16. Jansen G, Muskiet FAJ, Schierbeek H, et al: Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin Chim Acta 157:277-294, 1986
17. Schweitzer S, Shin Y, Jakobs C, et al: Long-term outcome in 134 patients with galactosemia. Eur J Pediatr 152:36-43, 1993
18. Lai K, Langley SD, Singh RH, et al: A prevalent mutation for galactosemia among black Americans. J Pediatr 128:89-95, 1996
19. Baker L, Mellman WJ, Tedesco TA, et al: Galactosemia: Symptomatic and asymptomatic homozygotes in one Negro sibship. J Pediatr 68:551-558, 1966
20. Rogers S, Holtzapple PG, Mellman WJ, et al: Characteristics of galactose-1-phosphate uridyltransferase in intestinal mucosa of normal and galactosemic humans. Metabolism 19:701-708, 1970
21. Segal S, Rogers S, Holtzapple PG: Liver galactose-1-phosphate uridyltransferase: Activity in normal and galactosemic subjects. J Clin Invest 50:500-506, 1971
22. 14C]galactitol in mammalian tissue. Biochim Biophys Acta 156:9-16, 1968
23. Berry GT, Nissim I, Lin Z, et al: Endogenous synthesis of galactose in normal man and patients with hereditary galactosemia. Lancet 346:1073-1074, 1995
24. Hayman S, Kinoshita JH: Isolation and properties of lens aldose reductase. J Biol Chem 210:877-882, 1965
25. Bohren KM, Bullock B, Gably WB: The aldo-keto reductase superfamily. cDNA's and deduced amino acid sequences of human aldehyde and aldose reductase. J Biol Chem 264:9547-9551, 1989
26. Grundmann U, Bohn U, Obermeier R, et al: Cloning and prokaryotic expression of a biologically active human placental aldose reductase. DNA Cell Biol 9:149-157, 1990
27. Gitzelmann R, Wells HJ, Segal S: Galactose metabolism in a patient with hereditary galactokinase deficiency. Eur J Clin Invest 4:79-84, 1974
28. Berry GT, Palmieri MJ, Gross K, et al: The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency. J Inherit Metab Dis 16:91-100, 1993
29. Donnell GN, Bergren WR, Perry G, et al: Galactose-1-phosphate in galactosemia. Pediatrics 31:802-810, 1963
30. Schwarz HP, Schaefer T, Bachman C: Galactose and galactitol in the urine of children with compound heterozygosity for Duarte variant and classic galactosemia after an oral galactose load. Clin Chem 31:420-422, 1985
31. Cuatrecasas P, Segal S: Galactose conversion to D-xylulose: An alternate route of galactose metabolism. Science 153:549-551, 1966
32. 14C galactose by patients with congenital galactosemia: Evidence for a direct oxidative pathway. Am J Med 44:340-347, 1968
33. Gitzelmann R: Hereditary galactose kinase deficiency, a newly recognized form of juvenile cataracts. Pediatr Res 1:14-23, 1967
34. Datiles MB, Fukui H, Kuwabora T, et al: Galactose cataract prevention with sorbinil, an aldose reductase inhibitor. A light microscopic study. Invest Ophthalmol Vis Sci 22:174-179, 1982
35. Unakar NJ, Tsui JY, Anthony P, et al: Aldose reductase inhibitors and galactose toxicity in neonatal and maternal rat lenses. J Ocul Pharmacol 9:341-353, 1993
36. Kuck JFR: Response of the mouse lenses to high concentrations of glucose or galactose. Ophthalmol Res 1:166-174, 1993
37. Jakobs C, Warner TG, Sweetman L, et al: Stable isotope delution analysis of galactitol in amniotic fluid: An accurate approach to prenatal diagnosis of galactosemia. Pediatr Res 18:714-718, 1984
38. Huttenlocher PR, Hellman RE, Hsia YE: Pseudotumor cerebri in galactosemia. J Pediatr 76:902-905, 1970
39. Litman N, Kanter AI, Finberg L: Galactokinase deficiency presenting as pseudotumor cerebri. J Pediatr 86:410-412, 1975
40. Miller LR, Gordon GB, Bensch K: Cytologic alterations in hereditary metabolic disorders. I. The effects of galactose on galactosemia fibroblasts in vitro. Lab Invest 19:428-436, 1968
41. Robison WG, Nagata M, Lauer N, et al: Diabetic-like retinopathy in rats presented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 30:2285-2292, 1989
42. Mizisin AP, Powell HC: Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 52:78-86, 1993